VanEck Biotech ETF
Ticker
BBH
ISIN
US92189F726
Price
USD 160.38
Change Today
+2.42 / 1.532 %
Price 1 year ago
148.41 / 8.069 %
Morningstar
2
52 Week Low
148.64
52 Week High
182.72
200 Day Moving Average 169.71
169.71
50-day Moving Average
173.84
Price evolution
Yearly returns
Peers comparison
Risk factors
1 year
| Parameter | Value |
|---|---|
| Sharpe Ratio | 1.95 |
| Sortino Ratio | 0.92 |
| Maximum Drawdown | -3.01% |
| Maximum Drawdown Date | 2023-12-20 |
| Calmar Ratio | -36.47 |
1 year
| Parameter | Value |
|---|---|
| Return | 4.69 |
| Volatility | 7.103% |
| Alpha | +8.83 |
| Beta | None |
| R Squared | +73.15 |
History
| Parameter | Value |
|---|---|
| Average Annual Return | 13.904% |
| Average Annual Volatility | 27.737% |
| Sharpe Ratio | 0.50 |
| Sortino Ratio | 0.57 |
| Maximum Drawdown | -71.0% |
| Maximum Drawdown Date | 2002-07-10 |
| Calmar Ratio | -0.19 |
Company information
Summary
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Market
US
Category
Health
Expense Ratio
0.35%
Fund family
VanEck
Morningstar
2
Yield
0.0052
Exchange
NGM
| Sector | Weight |
|---|---|
| Healthcare | 99.93% |
| Realestate | 0.00% |
| Consumer cyclical | 0.00% |
| Basic materials | 0.00% |
| Consumer defensive | 0.00% |
| Technology | 0.00% |
| Communication services | 0.00% |
| Financial services | 0.00% |
| Utilities | 0.00% |
| Industrials | 0.00% |
| Energy | 0.00% |
| Country | Ratio |
|---|---|
| United States | 87.72 |
| Denmark | 4.71 |
| China | 3.83 |
| Germany | 2.94 |
| Switzerland | 0.81 |
| Argentina | 0.00 |
| Australia | 0.00 |
| Austria | 0.00 |
| Belgium | 0.00 |
| Brazil | 0.00 |
Holdings
| Symbol | Name | Allocation |
|---|---|---|
| AMGN | Amgen Inc | 8.78% |
| MRNA | Moderna Inc | 5.92% |
| GILD | Gilead Sciences Inc | 5.41% |
| ILMN | Illumina Inc | 5.32% |
| REGN | Regeneron Pharmaceuticals Inc | 5.22% |
| ALXN | Alexion Pharmaceuticals Inc | 5.0% |
| IQV | IQVIA Holdings Inc | 4.94% |
| CRL | Charles River Laboratories International Inc | 4.64% |
| VRTX | Vertex Pharmaceuticals Inc | 4.6% |
| EXAS | Exact Sciences Corp | 4.58% |
Alternative funds
| Ticker | Name | Isin | Exchange | Expenses | Morningstar | Alpha | Beta |
|---|---|---|---|---|---|---|---|
| FR0007057625.PA | Gestys Santé Biotech | FR000705762 | YHD | 4.13% | 5 | Candriam World Alternative Alphamax C EUR | |
| IE00B3XLHR60.IR | Polar Capital Biotechnology R USD Inc | IE00B3XLHR60 | YHD | 5 | +15.62 | +1.17 | |
| IE00B42P0H75.IR | Polar Capital Biotechnology I GBP Inc | IE00B42P0H75 | ISE | 5 | |||
| IE00B42Z4531.IR | Polar Capital Funds PLC - Biotechnology Fund I Inc | IE00B42Z4531 | ISE | 2.20% | 5 | +16.08 | +1.17 |
| IE00BF23BV98.IR | Polar Capital Biotechnology S USD Inc | IE00BF23BV98 | YHD | 5 | +16.35 | +1.17 | |
| IE00BF23BW06.IR | Polar Capital Biotechnology S GBP Inc | IE00BF23BW06 | ISE | 5 |
Sustainability scores
Events
Indicators
Glossary
- Momentum
- A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
- Inertia
- In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
- Relative Strength Index (RSI)
- A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
- Fibonacci's Weighted Moving Average
- A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
- Williams %R
- A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
- Relative Volatility Index (RVI)
- A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
- Commodity Channel Index (CCI)
- A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.